Wenshen Xiaozheng Tang alleviates fibrosis in endometriosis by regulating differentiation and paracrine signaling of endometrium-derived mesenchymal stem cells

Bibliographic Data

ID14729348
AuthorsZhenzhen Zhang (0000-0001-6195-0411, Nanjing University of Chinese Medicine, corresponding author), Xue Zhou (0000-0002-9365-5887, Nanjing University of Chinese Medicine), Lu Xia (0000-0003-1859-9755, Nanjing University of Chinese Medicine), Nan Li (0009-0000-4562-451X, Nanjing University of Chinese Medicine), Shihan Xu (0009-0001-5001-9733, Nanjing University of Chinese Medicine), Xiaohong Dong (0009-0008-9157-8970, Nanjing University of Chinese Medicine), Li Zhu (0000-0003-0179-6496, Nanjing University of Chinese Medicine), Meihua Huang (Nanjing University of Chinese Medicine), Guiping Wan (0000-0001-6940-938X, Nanjing University of Chinese Medicine, corresponding author)
Year2025
Volume336
Pages118724
Publication date2025-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2024.118724
PMID39181283
OpenAlexW4401799328
LanguageEN
References cited36

WXT improved fibrosis in endometriosis by regulating differentiation and paracrine signaling of eMSCs. Thrombospondin 4, whose release from ectopic eMSCs is inhibited by WXT, may be a potential target for the treatment of endometriosis

Biology · Decoction · Endometriosis · Endometrium · Fibrosis · Mesenchymal stem cell · Paracrine signalling · Pathology · Receptor · Stem cell · Traditional medicine · Endometrial and Cervical Cancer Treatments · Endometriosis Research and Treatment · Medicine · Uterine Myomas and Treatments · Cancer Research · Cell Biology · Internal Medicine